|
|
Also indexed as: Bioflavonoids
What do they do? Flavonoids are a class of water-soluble plant
pigments. Flavonoids are broken down into categories, though the issue of how to divide them
is not universally agreed upon. One system breaks flavonoids into isoflavones, anthocyanidins,
flavans, flavonols, flavones, and flavanones.1 Some of the best-known flavonoids,
such as genistein in soy, and
quercetin in onions, can be considered
subcategories of categories. Although they are all structurally related, their functions are
different. Flavonoids also include hesperidin, rutin, citrus flavonoids, and a variety of
other supplements.
While they are not considered essential nutrients, some flavonoids support health by
strengthening capillaries and other connective tissue, and some function as anti-inflammatory,
antihistaminic, and antiviral agents. Quercetin has been
reported to block the “sorbitol pathway” that is linked to many problems
associated with diabetes. Rutin and several other
flavonoids may also protect blood vessels.
As antioxidants, some flavonoids, such as quercetin,
protect LDL cholesterol from oxidative damage.
Others, such as the anthocyanidins from bilberry, purple
cabbage, and grapes, may help protect the lens of the
eye from cataracts. Animal research suggests that
naringenin, found in grapefruit, may have anticancer activity.2 Soy isoflavones are also currently being studied to see if they
help fight cancer.
In a small, preliminary trial, rutoside (500 mg twice daily), a derivative of the
flavonoid, rutin, combined with vitamin C (500 mg twice
daily) produced marked improvement in three women with progressive pigmented purpura (PPP), a
mild skin condition.3 Although not a serious medical condition, cosmetic concerns
lead persons with PPP to seek treatment with a variety of drugs. The vitamin C/rutoside
combination represents a promising, non-toxic alternative to these drug treatments, but
larger, controlled trials are needed to confirm these preliminary results.
Flavonoids have been used
in connection with the following conditions (refer to the individual
health concern for complete information):
Who is likely to be deficient? Flavonoid deficiencies have not
been reported.
How much is usually taken? Flavonoid supplements are not
required to prevent deficiencies in people eating a healthy diet. Healthcare practitioners
commonly recommend 1,000 mg of citrus flavonoids taken one to three times per day.
Alternatively, 240–600 mg of bilberry (standardized
to 25% anthcyanosides) may be taken per day.
Are there any side effects or interactions? No consistent side
effects have been linked to the flavonoids except for catechin, which can occasionally cause
fever, anemia from breakdown of red blood cells, and
hives.4 5 These side effects subsided when treatment was
discontinued.
In 1980, quercetin was reported to induce cancer in
animals.6 Most further research did not find this to be true, however.7
8 While quercetin is mutagenic in test tube studies, it does not appear to be
mutagenic in animal studies.9 In fact, quercetin has been found to inhibit both
tumor promoters10 and human cancer cells.11 People who eat high levels
of flavonoids have been found to have an overall lower risk of getting a wide variety
of cancers,12 though preliminary human
research studying only foods high in quercetin has found no relation to cancer risk one way or
the other.13 Despite the confusion, in recent years experts have shifted their view
of quercetin from concerns that it might cause cancer in test tube studies to guarded hope
that quercetin has anticancer effects in humans.14
The flavonoids work in conjunction with vitamin C.
Citrus flavonoids, in particular, improve the absorption of vitamin C.15
16
Are there any drug interactions? Certain medications may
interact with flavonoids. Refer to the drug
interactions safety check for a list of those medications.
References:
1. Peterson J, Dwyer J. Taxonomic classification helps identify
flavonoid-containing foods on a semiquantitative food frequency questionnaire. J Am Diet
Assoc 1998;98:682–5.
2. So FV, Guthrie N, Chambers AF, et al. Inhibition of human breast
cancer cell proliferation and delay of mammary tumorigenesis by flavonoids and citrus juices.
Nutr Cancer 1996;26:167–81.
3. Reinhold U, Seiter S, Ugurel S, Tilgen W. Treatment of progressive
pigmented purpura with oral bioflavonoids and ascorbic acid: an open pilot study in 3
patients. J Am Acad Dermatol 1999;41(2 Pt 1):207–8.
4. Bar-Meir S, Halpern Z, Gutman M, et al. Effect of (+)-cyanidanol-3 on
chronic active hepatitis: a double-blind controlled trial. Gut
1985;26:975–9.
5. Conn HO. Cyanidanol: will a hepatotrophic drug from Europe go west?
Hepatology 1983;3:121–3 [review].
6. Pamukcu AM, Yalciner S, Hatcher JF, Bryan GT. Quercetin, a rat
intestinal and bladder carcinogen present in bracken fern (Pteridium
aquilinum). Cancer Res 1980;40:3468–72.
7. Hirono I, Ueno I, Hosaka S, et al. Carcinogenicity examination of
quercetin and rutin in ACI rats. Cancer Lett 1981;13:15–21.
8. Saito D, Shirai A, Matsushima T, et al. Test of carcinogenicity of
quercetin, a widely distributed mutagen in food. Teratog Carcinog Mutagen
1980;1:213–21.
9. Aeschbacher H-U, Meier H, Ruch E. Nonmutagenicity in vivo of
the food flavonol quercetin. Nutr Cancer 1982;2:90.
10. Nishino H, Nishino A, Iwashima A, et al. Quercetin inhibits the
action of 12-O-tetradecanoylphorbol-13-acetate, a tumor promoter. Oncology
1984;41:120–3.
11. Kuo SM. Antiproliferative potency of structurally distinct dietary
flavonoids on human colon cancer cells. Cancer Lett 1996;110:41–8.
12. Knekt P, Jävinen R, Seppänen R, et al. Dietary flavonoids
and the risk of lung cancer and other malignant neoplasms. Am J Epidemiol
1997;146:223–30.
13. Hertog M, Feskens EJM, Hollman PCH, et al. Dietary flavonoids and
cancer risk in the Zutphen Elderly Study. Nutr Cancer 1994;22:175–84.
14. Stavric B. Quercetin in our diet: from potent mutagen to probable
anticarcinogen. Clin Biochem 1994;27:245–8.
15. Vinson JA, Bose P. Comparative bioavailability to humans of ascorbic
acid alone or in a citrus extract. Am J Clin Nutr 1988;48:601–4.
16. Vinson JA, Bose P. Comparative bioavailability of synthetic and
natural vitamin C in guinea pigs. Nutr Rep Int 1983;27:875–9.
Copyright © 2002 Healthnotes, Inc. All rights reserved.
www.healthnotes.com
Learn more about Healthnotes, the company.
Learn more about the authors of Healthnotes.
The information presented in Healthnotes is for informational
purposes only. It is based on scientific studies (human, animal, or in vitro),
clinical experience, or traditional usage as cited in each article. The results reported may
not necessarily occur in all individuals. For many of the conditions discussed, treatment with
prescription or over-the-counter medication is also available. Consult your doctor,
practitioner, and/or pharmacist for any health problem and before using any supplements or
before making any changes in prescribed medications. Information expires December 2003.
|
|
|